Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.
Clinical trial NCT04348695 · COMPLETED
Trial details
- NCT number
- NCT04348695
- Sponsor
- Fundación de investigación HM
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-12
- Primary completion
- 2021-01-31
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.